COVID-19 in ART: Perception and Experience

NCT04456010 | Completed

• 1 other identifier: RECHMPL20_0351
• Study Type: observational
• Target: 600
• Locations: 1 country
• Sites: 1

Brief Summary

Non-urgent medical care, such as fertility treatments, has been massively postponed during the past weeks due to the COVID19 pandemic. The lockdown and the closure of IVF centers might cause anxiety and depression among infertile couples, who are already exposed to the distressing experience of infertility and for whom the wait for a baby already appears unending. Few data are available regarding the impact of SARS-CoV-2 on pregnant women and foetus, or on fertility. This study aims to assess the views of infertile couple regarding the potential risks of COVID during their fertility treatment and their personal experience of the COVID pandemic and their expectation for further treatment .

Conditions

COVID19; Fertility Issues; ART

Keywords

fertility; risk perception; emotional experience

Outcome Measures

Primary Outcomes (1)

• Personal experience of the COVID19 pandemic and the discontinuation of their fertility treatment pandemic and the discontinuation

  Personal experience of the COVID19 pandemic and the discontinuation of their fertility treatment, via a survey

  1 day

Secondary Outcomes (2)

• Risk assessment

  1 day

• Patients'expectations regarding the management of an abrupt closure of the fertility center

  1 day

Study Arms (1)

Infertile couple

Infertile couple who had a fertility treatment prescribed during the past 9 months which was not completed yet.

Other: Questionnaire

Interventions

Questionnaire OTHER

Eligible patients will be selected from our electronical database and invited via email to participate.

Infertile couple

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Infertile couple (male and female) who had a fertility treatment prescribed during the past 9 months (prescription after October 1st, 2019) in the fertility department of Montpellier Hospital

You may qualify if:

• \- Men and women who had a fertility treatment prescribed during the past 9 months in our Fertility department

You may not qualify if:

• Patient attending for a fertility preservation
• Patient attending for a preimplantation genetic testing (PGT-M or PGT-SR)
• Patient not fluent in French

Sponsors & Collaborators

• University Hospital, Montpellier: lead

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

COVID-19; Infertility

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Genital Diseases; Urogenital Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Noémie Ranisavljevic, M.D., Ph.D

  University Hospital, Montpellier

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 15, 2020
• First Posted: July 2, 2020
• Study Start: June 1, 2020
• Primary Completion: July 30, 2020
• Study Completion: July 30, 2020
• Last Updated: December 29, 2020

Record last verified: 2020-12

Locations

FR (1)